Moreover, a recent study showed that prostate cancer cells secrete the Transient Receptor Potential Cation Channel Subfamily M Member 8 (TRPM8) into extracellular vesicles, which then function as a TLR3 agonist (38). This evidence concerns the gene TLR3 and prostate carcinoma.